Publications

You can use the filters to show only results that match your interests

Filter publications
341 publications by Medicines and Healthcare products Regulatory Agency ×
Get updates to this list email feed

Copy and paste this URL in to your feed reader

  1. Suspended and revoked licences for manufacturers and wholesalers of medicines

  2. Notified bodies for medical devices

  3. Medical devices: UK notified bodies

  4. Early access to medicines scheme (EAMS) scientific opinion: Raxone to treat the decline of respiratory function in patients with Duchenne Muscular Dystrophy

  5. Better consultations, better evidence

    • MHRA
    • Research and analysis
  6. Drug Safety Update: monthly PDF newsletter

    • MHRA
    • Guidance
  7. Human and veterinary medicines: register of licensed manufacturing sites 2017

  8. Human and veterinary medicines: register of licensed wholesale distribution sites

  9. Advertising investigations: May 2017

  10. Post-implementation Review of the Human Medicines Regulations 2012 (MLX 391)

    • MHRA
    • Open consultation
  11. Early access to medicine scheme (EAMS) scientific opinion: Oxervate for the treatment of moderate or severe neurotrophic keratitis

  12. Parallel import licences granted in May 2017

  13. Marketing authorisations granted in May 2017

  14. Medicines: terminated and cancelled manufacturing and wholesale dealer licences

  15. Early access to medicines scheme: expired scientific opinions

    • MHRA
    • Decision
  16. Register of brokers authorised to deal in human medicines

  17. Medicines: new manufacturing and wholesale dealer licences

  18. MHRA: business impact target

    • MHRA
    • Research and analysis
  19. Clinical trials for medicines: authorisation assessment performance

    • MHRA
    • Transparency data
  20. Early access to medicines scheme applications: pending, refused, granted

    • MHRA
    • Official Statistics
  21. Medicines: licensing time-based performance measures

    • MHRA
    • Official Statistics
  22. MHRA: requests under the Freedom of Information Act (FOIA)

    • MHRA
    • FOI release
  23. Advertising investigations: April 2017

  24. Marketing authorisations granted in April 2017

  25. Parallel import licences granted in April 2017

  26. Early access to medicines scheme (EAMS) scientific opinion: Glecaprevir/Pibrentasvir for the treatment of chronic hepatitis C (HCV) infection in adults

  27. Advertising investigations: March 2017

  28. Medicines and Healthcare products Regulatory Agency spending over £25,000: 2016 to 2017

    • MHRA
    • Transparency data
  29. Medical devices: software applications (apps)

  30. Medicines and Healthcare products Regulatory Agency Business Plan 2017 to 18

    • MHRA
    • Corporate report
  31. Good manufacturing practice inspection deficiencies

    • MHRA
    • Official Statistics
  32. MHRA: policy for handling conflicts of interest

    • MHRA
    • Corporate report
  33. Patient group directions (PGDs)

    • MHRA
    • Guidance
  34. Parallel import licences granted in March 2017

  35. Marketing authorisations granted in March 2017

  36. Toolkit on the risks of valproate medicines in female patients

  37. MHRA fees

    • MHRA
    • Statutory guidance
  38. Common issues identified during clinical trial applications

    • MHRA
    • Guidance
  39. Proposal to make Dovonex Psoriasis Ointment available from Pharmacies

    • MHRA
    • Closed consultation
  40. Medical devices: Virtual Manufacturing replaces Own Brand Labelling